Healthtech Late Stage Investors & VC Firms
847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.
CPE
BeijingGrowth–Late Stage
Wellcome Trust
LondonSeed–Late Stage
3H Health Investment
ShanghaiSeries A–Late Stage
AFK Sistema
MoscowGrowth–Late Stage
Aflac Ventures Japan
TokyoSeed–Late Stage
Altas Partners Inc.
TorontoGrowth–Late Stage
Boyu Capital
George Town, Grand CaymanGrowth–Late Stage
CBC Group
SingaporeSeed–Late Stage
China Merchants Capital
ShenzhenGrowth–Late Stage
Chow Tai Fook Enterprises
Hong KongGrowth–Late Stage
CICC
BeijingGrowth–Late Stage
Claypond Capital
BengaluruGrowth–Late Stage
Clermont Group
SingaporeGrowth–Late Stage
Everbright Investments
Hong KongGrowth–Late Stage
Exome Asset Management
New YorkGrowth–Late Stage
FountainVest Partners
Grand CaymanGrowth–Late Stage
Healthequity
BarcelonaSeed–Late Stage
Imperial Capital Group Ltd
TorontoGrowth–Late Stage
Innogest Capital
Late Stage
IP Group
LondonSeed–Late Stage
LAFISE Investment Management
Growth–Late Stage
Onex Corporation
Englewood CliffsGrowth–Late Stage
Peloton Capital Management
Toronto, OntarioGrowth–Late Stage
Persistence Capital Partners
MontrealGrowth–Late Stage
Related lists
Healthtech Investors & VC Firms (3208)Late Stage Investors & VC Firms (2864)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Late Stage Investors & VC Firms in United States (1101)Late Stage Investors & VC Firms in Global (857)
Data sourced from public filings and firms' own websites — see our methodology.